Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen slips as FDA extends review of MS drug
Biogen slips as FDA extends review of MS drug
Biogen slips as FDA extends review of MS drug
Submitted by
admin
on October 20, 2012 - 10:29am
Source:
Yahoo/AP
News Tags:
Biogen
BG-12
MS
multiple sclerosis
Headline:
Biogen slips as FDA extends review of MS drug
Do Not Allow Advertisers to Use My Personal information
